PROTECTIVE LIFE CORPORATION – Trademark Portfolio
Entity Type: 03
PROTECTIVE LIFE CORPORATION holds 49 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 36 (Insurance & Financial) — 44 filings in this category. The portfolio also extends into Class 42 (Computer & Scientific) across 3 Nice Classification classes. Currently, 1 trademark is registered. Notable registered marks include LEGEND SERIES. The owner is based in BIRMINGHAM, AL.
2801 HIGHWAY 280 SOUTH
BIRMINGHAM, AL 35223
Showing of trademarks Trademarks
Trademark Classifications
PROTECTIVE LIFE CORPORATION's trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Insurance; financial affairs; monetary affairs; real estate affairs
Scientific and technological services; industrial analysis and research services
Advertising; business management; business administration; office functions
Frequently Asked Questions
How many trademarks does PROTECTIVE LIFE CORPORATION have?
PROTECTIVE LIFE CORPORATION has 49 U.S. trademarks filed with the USPTO. Of these, 1 registered, 9 abandoned, 39 cancelled.
What trademark classes does PROTECTIVE LIFE CORPORATION file in?
PROTECTIVE LIFE CORPORATION files trademarks across 3 Nice Classification classes. The most active classes are Class 36 (Insurance & Financial), Class 42 (Computer & Scientific), Class 35 (Advertising & Business). Class 36 covers insurance; financial affairs; monetary affairs; real estate affairs.
What are PROTECTIVE LIFE CORPORATION's most well-known trademarks?
PROTECTIVE LIFE CORPORATION's registered trademark portfolio includes well-known marks such as LEGEND SERIES. These are among 1 currently registered trademark in the portfolio.
What is PROTECTIVE LIFE CORPORATION's trademark registration success rate?
PROTECTIVE LIFE CORPORATION has a 2% trademark registration rate, with 1 out of 49 resolved applications resulting in successful registration. Currently, 0 applications are pending review.